News | Neuro Imaging | February 06, 2017

MRI Reveals Facial Recognition Part of Brain Continues to Grow in Adulthood

Study finds that while facial identification improves with age, place recognition stays the same

qMRI, facial recognition, brain region growth, adulthood, Science journal study

February 1, 2017 — In humans, the part of the brain that's responsible for face recognition continues to grow into adulthood, according to a new study published in Science. The results are surprising, since brain development is largely thought to involve synaptic pruning, rather than growth. The ability to recognize faces, which is critical for everyday social interactions, improves from childhood to adulthood.

In seeking to better understand brain activity behind facial recognition, Jesse Gomez et al. used quantitative magnetic resonance imaging (qMRI) to compare brain tissue across individuals. In 22 children and 25 adults, they compared recognition test results of faces and places with qMRI data that corresponds with the respective brain regions.

Intriguingly, the region of the brain that helps people recognize faces was found to increase in relative size in adults, while the region that helps people recognize places was found to stay the same. These results were confirmed in the postmortem analysis of adult brains. Modeling suggests that changes in myelination, the fatty white substance that surrounds the axons of some nerve cells, is not sufficient alone to explain this expansion of the brain region. Thus the authors propose that it may be caused by an increase in cell bodies, dendritic structures and myelin sheath.

For more information: www.science.sciencemag.org

References

Gomez, J., Barnett, M.A., Natu, V., Mezer, A., et al. "Microstructural proliferation in human cortex is coupled with the development of face processing," Science. Published Jan. 6, 2017. DOI: 10.1126/science.aag0311

Related Content

Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco

Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco

Feature | Contrast Media | July 18, 2019 | By Greg Freiherr
Macrocyclic contrast agents have the best safety profile of all the magnetic resonance (MR) contrast media that are n
AAPM 2019 Features More Than 40 Presentations on ViewRay's MRIdian MRI-guided Radiotherapy
News | Image Guided Radiation Therapy (IGRT) | July 16, 2019
ViewRay Inc. announced that the company's MRIdian System is the focus of more than 40 abstracts selected by the...
FDA Approves Bayer's Gadavist Contrast for Cardiac MRI in Adult Coronary Artery Disease Patients
Technology | Contrast Media | July 15, 2019
The U.S. Food and Drug Administration (FDA) has approved Gadavist injection for use in cardiac magnetic resonance...
Insightec's Exablate Neuro Approved With GE Signa Premier MRI in U.S. and Europe
News | Focused Ultrasound Therapy | July 10, 2019
GE Healthcare and Insightec announced U.S. Food and Drug Administration (FDA) approval and CE mark for Insightec’s...
Delta T1 Maps Provide Quantitative, Automated Solution to Assess Brain Tumor Burden
News | Neuro Imaging | July 05, 2019
Imaging Biometrics LLC (IB) a subsidiary of IQ-AI Ltd., is highlighting a recently published study in the American...
Medic Vision Wins Japanese PMDA Clearance for iQMR Image Reconstruction Solution
News | Magnetic Resonance Imaging (MRI) | July 05, 2019
Medic Vision Imaging Solutions announced that its 3-D iterative image reconstruction technology for shortening magnetic...
Bay Labs Announces New Echocardiography Guidance Software Data at ASE 2019 Scientific Sessions
News | Cardiovascular Ultrasound | June 20, 2019
Bay Labs announced that new data on the company’s first-of-its-kind deep learning investigational guidance software...
Third FDA Clearance Announced for Zebra-Med's AI Solution for Brain Bleed Alerts
Technology | Artificial Intelligence | June 19, 2019
Zebra Medical Vision announced it has received its third U.S. Food and Drug Administration (FDA) 510(k) clearance for...
LVivo EF Comparable to MRI, Contrast Echo in Assessing Ejection Fraction
News | Cardiovascular Ultrasound | June 19, 2019
DiA Imaging Analysis announced the presentation of two studies assessing the performance and accuracy of the company's...